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Abstract
Background: Fibroblast growth factors (Fgfs) are important regulators of cerebral cortex
development. Fgf2, Fgf8 and Fgf17 promote growth and specification of rostromedial (frontoparietal)
cortical areas. Recently, the function of Fgf15 in antagonizing Fgf8 in the rostral signaling center was also
reported. However, regulation of caudal area formation by Fgf signaling remains unknown.
Results: In mutant mice with constitutive activation of Fgf receptor 3 (Fgfr3) in the forebrain,
surface area of the caudolateral cortex was markedly expanded at early postnatal stage, while
rostromedial surface area remained normal. Cortical thickness was also increased in caudal regions.
The expression domain and levels of Fgf8, as well as overall patterning, were unchanged. In
contrast, the changes in caudolateral surface area were associated with accelerated cell cycle in
early stages of neurogenesis without an alteration of cell cycle exit. Moreover, a marked
overproduction of intermediate neuronal progenitors was observed in later stages, indicating
prolongation of neurogenesis.
Conclusion: Activation of Fgfr3 selectively promotes growth of caudolateral (occipitotemporal)
cortex. These observations support the 'radial unit' and 'radial amplification' hypotheses and may
explain premature sulcation of the occipitotemporal cortex in thanatophoric dysplasia, a human
FGFR3 disorder. Together with previous work, this study suggests that formation of rostral and
caudal areas are differentially regulated by Fgf signaling in the cerebral cortex.
Background
The mammalian cerebral cortex consists of multiple
cortical areas with specific functions, each of which
connects to a specific area of the body and within the
cortex [1]. Patterning and neurogenesis are two key events
that influence cortical area formation. The cortical wiring is
established based on the prospective area boundaries, the
'protomap', specified by combinations of transcription
factors, such as Pax6 and Emx2, expressed in graded
patterns in the cortical ventricular zone (VZ) [2-4].
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Transcription factor expression gradients are modified by
morphogens, expressed focally in the signaling centers
during early forebrain development. Fgf8 is expressed in
the rostral signaling center, and controls transcription
factor expression gradients and area specification by its
function in patterning. Concurrently, the cortex grows in
size by controlled proliferation and differentiation of
progenitor cells in the VZ and subventricular zone (SVZ).
This process, neurogenesis, is also regulated by Fgf8, as well
as by other Fgfs.
Fgf ligands comprise a family of 22 polypeptides that
play a variety of roles during brain development [5]. Fgf8
and Fgf17 are expressed in the rostral-most region of the
cortical primordium, and specify the frontal cortex and
its subdivisions [6-9]. In addition, Fgf8 is shown to
regulate the size of the forebrain, especially rostral
regions [7, 8]. Likewise, Fgf2 knockout mice showed
significant reductions of neuronal density and cortical
thickness in rostral areas, indicating its important role in
neurogenesis [10-12]. Furthermore, a recent study of
Fgf15 knockout mice revealed a function of Fgf15 in the
rostral signaling center influencing patterning in a
fashion opposite of Fgf8, suppressing proliferation, and
promoting differentiation of cortical progenitors [13]. In
contrast, no specific role for Fgfs has been found in
regulating formation of caudal cortical areas.
The effects of Fgfs are mediated by the four high-affinity
receptor tyrosine kinases, Fgfrs [14, 15]. Signaling by
Fgfrs was shown to be necessary for growth of rostral, as
well as caudal, cortical regions [16]. However, current
knowledge concerning the specific roles of individual
receptors is limited, presumably due to functional
redundancy. Nonetheless, some functions of Fgfrs have
emerged. Forebrain-specific knockout of Fgfr1 (Foxg1-
Cre;Fgfr1flox/flox) showed a loss of the olfactory bulb,
mostly owing to a decrease in progenitor proliferation
leading to a deficit in initial bulb evagination [17]. A
subtle shift of Pax6 and Emx2 expressions also indicated
an alteration in early patterning in this study. Changes in
gene expression were more thoroughly assessed by
microarray performed in developing cortex in this
model at embryonic day (E)12.5, which confirmed the
involvement of Fgfr1 signaling in the regulation of
cortical patterning genes [18]. Dorso-ventral patterning
defects were further demonstrated in a double knockout
study, where deletion of both Fgfr1 and Fgfr3 resulted in
a loss of neurogenesis in ventromedial regions, while
deletion of both Fgfr1 and Fgfr2 led to a loss of ventral
identities owing to dorsoventral patterning defects at
E12.5 [19]. In addition, signaling via Fgfr1, but not
Fgfr3, was shown to be required for growth of midline
progenitor cell types at E14.5-E16.5 and formation of
commissural axon tracts [20, 21].
In vitro assays have shown that Fgfr3 responds highly to
Fgf8/17, and to Fgf2 [15, 22]. Fgfr3 is expressed in
progenitor cells in the neuroepithelium from E9.5 and in
the cortical VZ/SVZ throughout neurogenesis in mice
[23], but is not expressed in postmitotic cortical plate
neurons. Interestingly, Fgfr3 is expressed in a rostrome-
dial-low, caudolateral-high gradient in the cortical
primordium during E11.5-E13.5 [7, 24-26]. Fgfr3 knock-
out mice show skeletal overgrowth and deafness owing
to inner ear defects, indicating the role of Fgfr3 in
skeletal growth and hearing [27]. However, the role of
Fgfr3 in brain development has been uncertain. In
particular, Fgfr3 was reported to have no definite role
in cortical patterning [28]. Also, deletion of Fgfr3 did not
aggravate the effects of either Fgfr1 or Fgfr2 deletion in
the dorsal cortex and the midline [19, 20]. However, the
expected redundancy of Fgfr activities, and possible
subtleties in the Fgfr3-/-brain phenotype, could mask
Fgfr3 functions in cortical development.
A different perspective on the role of Fgfr3 in brain
development has emerged from gain-of-function mod-
els. We previously showed that mice expressing a
constitutively active mutant Fgfr3 allele displayed an
enlarged cerebral cortex with increased cortical thickness
and total cell number, mostly due to increased progeni-
tor proliferation [26, 29]. Furthermore, the increase in
progenitor proliferation in the cortical VZ was graded
along the rostrocaudal axis, with the highest effect in
caudal region during the early stages of neurogenesis at
E11-E13 [26]. Downstream activation of MAPK in E11.5
temporal cortex was largely responsible for this effect.
These conditional knock-in mouse models carry muta-
tions substituting the amino acid Lys644 to glutamic
acid (K644E) and to methionine (K644M) [30, 31]. The
mutant allele is knocked-in to the endogenous Fgfr3
locus, allowing expression of the mutant allele in a
fashion reflecting normal Fgfr3 expression domains and
levels. K644 mutations highly activate Fgfr3 signaling in
terms of kinase activity and autophosphorylation in vitro
[31-33]. BaF3, mouse pro-B cell line expressing Fgfr3
with this mutation, shows a mitogenic response both in
the absence of ligand (approximately 25% of full
response) and in a concentration-dependent manner
(an increasing response by a further addition of ligand)
with an overall 2- to 10-fold increase of response
compared to control [32].
The corresponding kinase-domain mutations in human
FGFR3 are known to cause a severe and fatal form of
achondroplasia, known as thanatophoric dysplasia (TD;
OMIM#187601). The cerebral neocortex in TD is
markedly enlarged (megalencephaly) and excessively
convoluted, especially in temporal and occipital lobes,
where sulcation begins prematurely [34]. In addition, TD
Neural Development 2009, 4:4 http://www.neuraldevelopment.com/content/4/1/4
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brains show severe hippocampal dysplasia with rudi-
mentary dentate gyrus, as well as numerous abnormal-
ities of the brainstem and cerebellum [34]. Therefore, the
study of Fgfr3 function presents a unique opportunity
whereby its biological significance in cerebral cortical
development can be directly compared in mice and
humans.
In the present study, we hypothesized that Fgfr3 may play a
role in formation of cortical areas by regulating patterning in
addition to progenitor proliferation and focused to analyze
cortical area formation and changes in cell cycle parameters.
We found that mice carrying biochemically activating
mutations in Fgfr3 presented a massive enlargement of the
caudolateral cortex surface area in early postnatal stage, with
relatively little change in the rostral cortex. The expression of
transcription factors remained mostly normal, indicating
that patterning of the cortex is influenced little by Fgfr3
activation. In contrast, cumulative bromodeoxyuridine
(BrdU) labeling revealed that the length of the G1 phase
(TG1) was 1.7 hours shorter in progenitors of the caudal
mutantVZcompared to thewild typeat E12.5. Therefore, the
expansion of caudal cortex surface area likely reflected
excessive proliferation of radial glia at early stages of
neurogenesis. Finally, cortical thickness was increased in
caudal areas of the Fgfr3 mutant mice, which may be
explained by a significant increase of intermediate neuronal
progenitors at late stages (E18.5), indicating a prolongation
of neurogenesis. In summary, this study reveals a unique
perturbation of cortical area formation with selective
expansion of the caudal cortex surface area, caused by
alteration of Fgf signaling along the Fgfr3 gradient.
Results
Selective expansion of caudolateral cortical areas in the
Fgfr3 mutant mice
We first addressed whether the change in Fgf signaling
along the graded expression of Fgfr3 could influence
formation of cortical areas, using mouse models with the
gain-of-function, kinase domain mutations targeted in
the Fgfr3 gene locus [30, 31]. These mice were originally
generated to represent the severe skeletal dysplasia. Early
lethality associated with the disease needed to be
prevented in order to successfully propagate the animal
model. It is known that the presence of an exogenous
fragment in the Fgfr3 locus suppresses transcription of
the Fgfr3 allele [35]. Taking advantage of this, we
designed the homologous recombination so that the
neo gene flanked by the loxP sequences was inserted in
intron 10 located near exon 15 containing the mutation
site (Fgfr3+/K644Eneo). Upon crosses with mice that express
Cre recombinase, the neo gene is removed and the allele
with Fgfr3mutation is transcribed (for example, EIIa-Cre;
Fgfr3+/K644E) [30, 31].
Formation of the cortical areas can be detected by
analyzing the projection of thalamocortical axons to the
cortex at postnatal week 1 in mice [4]. Ubiquitous
expression of the K644E mutation heterozygously (EIIa-
Cre;Fgfr3+/K644E) leads to lethality within postnatal day 1
(P1), possibly owing to the skeletal phenotype [30], and
is unsuitable for postnatal analysis of cortical areas. We
therefore tested the survival of mice with K644E and
K644M mutations [31] by crossing with Nestin- and
Foxg1-Cre mice, which allows expression of Cre recom-
binase preferentially in the brain. Nestin-Cre [36] drives
recombination in the central nervous system starting
from E11. In contrast, Foxg1-Cre [37] allows recombina-
tion starting from E8.5 in more limited regions, mainly
in the forebrain, although some other regions such as
facial and head ectoderm, mid-hindbrain junction, and
pharyngeal pouches are also shown to express Cre
recombinase. As the axonal growth from the diencepha-
lon would affect development of the neocortex, use of
Foxg1-Cre is advantageous. The result of the crosses
showed that, despite the lack of skeletal abnormalities,
the Foxg1-Cre;Fgfr3+/K644E offspring died within P1 (n > 8)
from unknown causes. In contrast, Nestin-Cre;Fgfr3+/K644E
and Foxg1-Cre;Fgfr3+/K644M offspring survived for more
than 3 weeks (n > 10 each genotype). We therefore
analyzed area formation using these lines.
Cortical area formationwas analyzed in early postnatalmice
by immunohistochemistry for the serotonin transport
protein 5-hydroxy-tryptamine (5-HTT), which detects tha-
lamocortical axon terminals, as well as cytochrome C
oxidase histochemistry, which visualizes the high cellular
metabolism associated with synaptic activities [6, 38, 39].
Areas including the primary somatosensory (S1) and
auditory (A1) areas were successfully visualized in Nestin-
Cre;Fgfr3+/K644E (Figure 1a, b) and Foxg1-Cre:Fgfr3+/K644M
(Figure 2a, b) in early postnatal stages. Surprisingly,
irregularity of the S1 shape was observed in Nestin-Cre;
Fgfr3+/K644E (Figure 1b); this was observed in all Nestin-Cre;
Fgfr3+/K644E samples analyzed (n > 14), although the
pattern of irregularity was not obviously consistent in each
sample. This phenotype was not present in Foxg1-Cre;Fgfr3+/
K644M cortices (n > 9; Figure 2b). The whisker pads of both
Nestin-Cre;Fgfr3+/K644E and Foxg1-Cre;Fgfr3+/K644M animals
were normal (data not shown). The cause of this particular
phenotype inNestin-Cre;Fgfr3+/K644E is likely to be attributed
to changes in the thalamus and brainstem, where Foxg1-Cre
does not drive expression of the mutant Fgfr3.
The position of S1 appeared to be rostrally shifted
(relative to the rostral and caudal poles) in Nestin-Cre;
Fgfr3+/K644E in comparison to wild-type littermates due
to surface area expansion, which was particularly
obvious in caudal regions (Figure 1a, b). A similar
relative rostral shift of S1 with caudal enlargement was
Neural Development 2009, 4:4 http://www.neuraldevelopment.com/content/4/1/4
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observed in Foxg1-Cre;Fgfr3+/K644M (Figure 2a, b). This
phenotype was evident in all samples analyzed (n > 14
and 9 in Nestin-Cre;Fgfr3+/K644E and Foxg1-Cre:Fgfr3+/
K644M, respectively). The appearance of the 'rostral shift'
could result from selective reduction of rostral surface
area or selective expansion of caudal area, or both. To
address these possibilities, we quantitatively analyzed
area location of the posteromedial barrel subfield
Figure 1
Rostral shift of cortical areas in Nestin-Cre;Fgfr3+/
K644E. (a, b) Cortical areas were visualized in tangential
sections of the flattened cortex of Nestin-Cre;Fgfr3+/K644E (b)
and wild-type (Wt) littermates (a) by immunohistochemistry
for the serotonin transport protein 5-hydroxy-tryptamine
(5-HTT). In (a, b), cortical hemispheres at postnatal day (P)
8.5 were dissected so that the primary somatosensory area
(S1), including the posteromedial barrel subfield (PMBSF),
was clearly displayed. Irregularity in the barrel pattern was
observed in Nestin-Cre;Fgfr3+/K644E (b, arrow). (c) Position of
the PMBSF was quantified by cytochrome C oxidase
histochemistry performed at P6.5, using C4 subfield as a
reference point, and presented as a frontal (F) and occipital
(O) ratio to the total cortical length (T). (d-f) Measurements
showed an increase in total and occipital length, while the
frontal length remained similar. (g, h) The F/T and O/T
length ratios clearly show that the PMBSF was rostrally
shifted in Nestin-Cre;Fgfr3+/K644E. (i) Position of the PMBSF
was quantified for the total (W), medial (M) and lateral (L)
lengths. (j-l) The total and lateral lengths were increased in
Nestin-Cre;Fgfr3+/K644E compared to wild type, while the
medial length was similar. (m, n) The M/W and L/W ratios
show that the PMBSF was medially shifted in Nestin-Cre;
Fgfr3+/K644E. Scale bar: 1 mm in (a, b).
Figure 2
Rostral shift of cortical areas in Foxg1-Cre;Fgfr3+/
K644M. (a, b) Formation of the cortical areas was analyzed in
the flattened cortex of Foxg1-Cre;Fgfr3+/K644M (b) and control
(a) at P6.5 by cytochrome C oxidase histochemistry. (c-e)
Measurements show an increase in total and occipital lengths
of the cortex, while the frontal length remained similar. (f, g)
The F/T and O/T length ratios clearly show that the PMBSF
was rostrally shifted in Foxg1-Cre;Fgfr3+/K644M. (h-j) The
lateral length of the cortex was increased in Foxg1-Cre;Fgfr3+/
K644M compared to control, while no significant difference
was observed in the total and medial lengths. (k, l) The L/W
ratio shows that the PMBSF was medially shifted in Foxg1-Cre;
Fgfr3+/K644M. Scale bar: 1 mm in (a, b).
Neural Development 2009, 4:4 http://www.neuraldevelopment.com/content/4/1/4
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(PMBSF) following previously established methods [39,
40] at P6.5 (Figure 1c, i and Table 1). The total and
occipital lengths of the cortex were increased by 33.7%
and 75.5%, respectively, in Nestin-Cre;Fgfr3+/K644E com-
pared to wild type, while the frontal length remained
similar (Figure 1d–f and Table 1). As a result, the ratio of
frontal-to-total length (F/T) was decreased by 19.0%,
while that of occipital-to-total length (O/T) was
increased by 34.2% (Figure 1g–h and Table 1), confirm-
ing the appearance of an overall 'rostral shift' in the
Nestin-Cre;Fgfr3
+/K644E
cortex. We also compared medio-
lateral positions of the PMBSF. The total and lateral
widths of the Nestin-Cre;Fgfr3+/K644E cortex were 32.1%
and 61.8% longer than wild type, respectively, while the
medial width did not change significantly (Figure 1j–l
and Table 1). The ratio of the medial-to-total width
(M/W) was decreased by 30.1%, while the lateral-to-total
width (L/W) was increased by 24.3%, indicating a
relative 'medial shift' (Figure 1m–n and Table 1). A
similar change in area dimensions was observed and
confirmed by quantitative analysis in the Foxg1-Cre;
Fgfr3+/K644M cortices (Figure 2 and Table 2).
Taken together, in the presence of the Fgfr3 kinase domain
mutation, the surface area of the caudal and lateral cortex
was particularly enlarged, while that of the rostral and
medial areas showed little change, leading to an overall
appearance of relative 'shifts' in rostral and medial direc-
tions towards the domain of less Fgfr3 expression.
Cortical patterning was unchanged in the Fgfr3 mutant
cortex
Positioning of cortical areas along the rostrocaudal and
lateromedial axes is initially determined by patterning
processes occurring early in cortical development. We
next studied whether activation of Fgfr3 perturbs the
expression of Fgf8 in the rostral signaling center at the
initial patterning stage (E9.5) and those of cortical
transcription factor gradients formed at E11.5-E13.5. For
the analysis of embryonic brains, we used a model in
Table 1: Summary of measurements of the PMBSF position in Nestin-Cre;Fgfr3+/K644E
Measurement Cont ± SD n Nes+/E ± SD n %Cont P-value
Rostrocaudal
Total length (T) (mm) 6.38 ± 0.42 10 8.52 ± 0.48 5 133.7 5.3 × 10-5
Frontal length (F) (mm) 3.85 ± 0.30 10 4.08 ± 0.23 4 106.1 NS
Occipital length (O) (mm) 2.66 ± 0.24 10 4.67 ± 0.24 4 175.5 1.5 × 10-5
Ratio F/T 0.60 ± 0.024 10 0.49 ± 0.019 4 81.0 3.9 × 10-5
Ratio O/T 0.42 ± 0.023 10 0.56 ± 0.036 4 134.2 1.7 × 10-3
Lateromedial
Total width (W) (mm) 4.60 ± 0.38 10 6.08 ± 0.38 5 132.1 8.9 × 10-5
Medial length (M) (mm) 1.94 ± 0.46 10 1.75 ± 0.15 4 90.2 NS
Lateral length (L) (mm) 2.73 ± 0.50 10 4.42 ± 0.40 4 161.8 2.9 × 10-4
Ratio M/W 0.42 ± 0.089 10 0.29 ± 0.041 4 69.9 3.6 × 10-3
Ratio L/W 0.59 ± 0.096 10 0.74 ± 0.038 4 124.3 1.6 × 10-3
Measurements were taken, as indicated in Figure 1c,i, to determine the rostrocaudal and lateromedial positions of the posteromedial barrel subfield
(PMBSF) in Nestin-Cre;Fgfr3+/K644E (Nes+/E) and its littermate control (Cont) cortices at postnatal day 6.5. Results are presented in the graph in
Figure 1d-g (rostrocaudal) and 1j-n (lateromedial positions). SD, standard deviation.
Table 2: Summary of measurements of the PMBSF position in Foxg1-Cre;Fgfr3+/K644M
Measurement Cont ± SD n Fox+/M ± SD n %Cont P-value
Rostrocaudal
Total length (T) (mm) 6.70 ± 0.51 7 7.42 ± 0.53 9 110.7 0.017
Frontal length (F) (mm) 3.75 ± 0.50 7 3.30 ± 0.44 9 88.0 NS
Occipital length (O) (mm) 2.84 ± 0.38 7 4.23 ± 0.24 9 148.9 1.0 × 10-5
Ratio F/T 0.56 ± 0.055 7 0.44 ± 0.032 9 78.6 8.0 × 10-4
Ratio O/T 0.42 ± 0.061 7 0.57 ± 0.023 9 132.6 4.6 × 10-4
Lateromedial
Total width (W) (mm) 5.09 ± 0.70 7 4.86 ± 0.52 9 95.5 NS
Medial length (M) (mm) 2.37 ± 0.58 7 1.90 ± 0.26 9 80.2 NS
Lateral length (L) (mm) 2.73 ± 0.28 7 3.27 ± 0.61 9 119.8 0.038
Ratio M/W 0.46 ± 0.072 7 0.39 ± 0.074 9 84.8 NS
Ratio L/W 0.54 ± 0.073 7 0.67 ± 0.068 9 124.1 4.3 × 10-3
Measurements were taken, as indicated in Figure 1c,i, to determine the rostrocaudal and lateromedial positions of the posteromedial barrel subfield
(PMBSF) in Foxg1-Cre;Fgfr3+/K644M (Fox+/M) and its littermate control (Cont) cortices at postnatal day 6.5. Results werare presented in the graph in
Figure 2c-g (rostrocaudal) and 2h-l (lateromedial positions). SD, standard deviation.
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which the Fgfr3 mutation is ubiquitously expressed (Ella-
Cre;Fgfr3+/K644E) [26, 29]. Use of EIIa-Cre is advanta-
geous as, under the cross with this line, a ubiquitous
promoter, EIIa, drives Cre recombination from the one-
cell zygote stage. In the conditional knock-in line,
expression of the mutant Fgfr3 allele remains under the
transcriptional regulation of the endogenous Fgfr3
promoter, and as such its expression faithfully reflects
the spaciotemporal expression of the endogenous Fgfr3
in Ella-Cre;Fgfr3+/K644E.
Whole mount in situ hybridization showed no obvious
differences in the expression domain or levels of Fgf8 in
wild type and Ella-Cre;Fgfr3+/K644E at E9.5 (n > 6; Figure
3a–d). No obvious change was detected in the
expression of Pax6 and Emx2 (Figure 3i–l), or Coup-
Tf1 at E11.5 and E13.5 (n > 3; Figure 3e, f, m–p).
Expression of Coup-Tf1 was also examined at E12.5 and
E14.5 on sagittal sections [26], where a somewhat less
steep gradient, possibly owing to an increase in expres-
sion at the rostral region, was observed. The presence of
subtle changes in expressions of these factors cannot be
excluded, but more precise quantitative methods are
required for their detection.
An interesting change was observed in the expression of
a cortical hem marker, Wnt2b [41]. Unlike in wild-type
embryos, Wnt2b expression did not extend to the most
caudal region of the cortical primordium in EIIa-Cre;
Fgfr3+/K644E (Figure 3g, h). This could indicate an
enlargement of the caudal region in EIIa-Cre;Fgfr3+/
K644E. Furthermore, the overall level of Wnt2b expression
appeared to be reduced, implicating Fgfr3 activity in a
perturbation of cortical hem properties.
Shorter cell cycle length in the caudal Fgfr3 mutant cortex
at E12.5
We have previously demonstrated the role of Fgfr3 in
controlling progenitor numbers during cortical develop-
ment [26, 29]. In this context, we predicted that the
cortical area phenotype described above might be
associated with changes in cell cycle parameters along
the Fgfr3 expression gradient. We therefore analyzed cell
cycle kinetics in the EIIa-Cre;Fgfr3+/K644E cortical primor-
dium at the onset of neurogenesis in rostral and caudal
regions using the established method [42] (Figure 4a, b).
The average total cell cycle length (Tc) of progenitors in
the dorsal VZ is reported to be 8.1, 10.2, and 11.4 hours
at E11.5, E12.5, and E13.5, respectively [43]. Based on
the Fgfr3 expression gradient known to be present during
E11.5-E13.5, we previously examined progenitor prolif-
eration by the BrdU pulse labeling method at each of
E11.5, E12.5, and E13.5 [26]. Increases in BrdU
incorporation in the mutant VZ in comparison to the
wild type were 10–20% at E11.5, while it was up to 46%
at E12.5 and E13.5. In this study, we selected E12.5 for
our analysis, as the difference in Tc may be too subtle to
detect at E11.5.
We performed cumulative BrdU labeling over a total
period of 11 hours, at 8 time points with intervals of 1.5
hours. The labeling index (LI) was then plotted at each
time point after initial BrdU injection (Figure 4c, d).
Four embryos per genotype and two counting boxes per
sample were used at each time point. As expected, the LI
progressed linearly with administration of further BrdU
injections, until BrdU labeling became saturated as
illustrated by the LI plateau. A similar linear progression
and the time to reach the LI plateau was observed in wild
Figure 3
Little change in gene expression patterning in the
EIIa-Cre;Fgfr3+/K644E cortical primordium. (a-d)
Expression of Fgf8 was examined by whole mount in situ
hybridization at E9.5. Focal expression of Fgf8 in the anterior
neural ridge was observed as expected (white arrowhead) in
wild type (Wt) (a, c), and a similar expression domain and
level of Fgf8 was observed in EIIa-Cre;Fgfr3+/K644E (b, d). (e, f,
m-p) Coup-Tf1 was expressed similarly in wild type (e, m, o)
and EIIa-Cre;Fgfr3+/K644E (f, n, p) at E11.5 (g, h) and E13.5 (m-
p). Panels (o, p) are medial views of (m, n), respectively. (g,
h) Wnt2b marked the caudal limit of the cortical hem
(arrows), indicating a selective expansion of the caudal
region in EIIa-Cre;Fgfr3+/K644E. Note the overall reduction in
expression level of Wnt2b in (h). No obvious difference was
observed in expression of Pax6 at E11.5 (i, j) and Emx2 at
E11.5 (k, l) between the wild-type (i, k) and EIIa-Cre;Fgfr3+/
K644E samples (j, l). Results presented here are
representatives of at least three independent hybridizations
(n > 3). Scale bars: 250 μm in (a, b); 100 μm in (c, d); 400 μm
in (e, f, i-l); 800 μm in (g, h, m-p).
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type and EIIa-Cre;Fgfr3+/K644E at the rostral level (Figure
4c). In contrast, the LI plateau was reached at an earlier
time point in EIIa-Cre;Fgfr3+/K644E compared to wild type
in the caudal region (Figure 4d), indicating that Tc was
reduced in EIIa-Cre;Fgfr3+/K644E compared to wild type.
In contrast, the growth fraction (GF) was similar in
rostral and caudal regions and in both wild type
and EIIa-Cre;Fgfr3+/K644E, showing 99% of cortical
progenitor cells proliferating at E12.5 (Table 3). This
value was consistent with a previous report [43].
Interestingly, the length of S phase (Ts) was approxi-
mately 40 minutes longer in cortical progenitors in the
rostral region compared to the caudal region in the wild
type (Table 3). The biological significance of this
variation is unknown. Comparing the wild-type and
EIIa-Cre;Fgfr3+/K644E samples, Ts was similar at each
rostral and caudal region. In contrast, Tc in the caudal
region showed a striking shortening of 1.61 hours
(1 hour 37 minutes) in EIIa-Cre;Fgfr3+/K644E compared
to wild type, while that in the rostral region remained
similar.
The average Tc of neuroepithelial cells is known to
increase as development proceeds, mainly due to
lengthening of TG1[43]. We further examined the
individual length of G1, G2 and M phase (TG1, TG2,
and TM, respectively) in the caudal region, where a
change in Tc was observed. Three embryos were used for
each genotype. With cumulative injections of BrdU, we
first determined the combined length of G2 and M
phases (TG2+M) based on the time taken to label all cells
in the M phase (mitotic cells). TG2+M is known to be
relatively constant and estimated to be around 2.0 hours
[43]. We therefore performed single injections of BrdU
for 1.5 and 2.0 hours, and then measured the percentage
of phospho-histone H3+ (pHH3+) mitotic cells that were
also labeled with BrdU. At 2 hours after BrdU injection,
all mitotic cells were BrdU+ in both wild type and EIIa-
Cre;Fgfr3+/K644E (n = 3). The mitotic index (MI) was
similar in wild type and EIIa-Cre;Fgfr3+/K644E along the
rostrocaudal axis (rostral, 0.061 ± 0.022 and 0.054 ±
0.016, respectively; caudal, 0.060 ± 0.019 and 0.074 ±
0.013, respectively; n = 6; not significant). Both TM and
TG2 were also similar in wild type and EIIa-Cre;Fgfr3
+/
K644E (Table 3). Finally, TG1 was shown to be 1.67 hours
(1 hour 40 minutes) shorter in EIIa-Cre;Fgfr3+/K644E
caudal cortex progenitors compared to wild type. There-
fore, the shorter Tc observed in the caudal region of the
EIIa-Cre;Fgfr3+/K644E cortical primordium was attributed
to a reduction of TG1.
Cell cycle exit in the Fgfr3 mutant cortex
was similar at E13.5
In contrast, there were no significant changes in cell cycle
exit in the EIIa-Cre;Fgfr3+/K644E cortical primordium at
E13.5 (Figure 5). BrdU was injected at E12.5 and
embryos were harvested after 24 hours. Double immu-
nohistochemistry was performed to visualize BrdU+ cells
Figure 4
Reduced cell cycle length in the caudal regionof theEIIa-
Cre;Fgfr3+/K644E cortical primordium at E12.5.
(a, b) Cumulative bromodeoxyuridine (BrdU) labeling was
performed at 8 time points between 0.5 and 11 hours at E12.5.
Four embryos per genotype and two counting boxes per sample
were used at each time point. Panels (a, b) are representative
wild-type coronal forebrain sections at the rostral (a) and caudal
levels (b). Equivalent levels of sections in EIIa-Cre;Fgfr3+/K644E
were selected usingmorphological landmarks. Scale bar: 670 μm.
(c, d) LI of EIIa-Cre;Fgfr3+/K644E (black circles) and wild type (Wt;
open squares) was plotted against each time point at the rostral
(c) and caudal levels (d). In contrast to the rostral region, which
showed similar profiles in EIIa-Cre;Fgfr3+/K644E and wild type (c),
the LI plateau was reached at an earlier time point in EIIa-Cre;
Fgfr3+/K644E compared to wild type in the caudal region (d),
indicating a shorter Tc-Ts.
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(those born during E12.5) and Ki67+ cells (those
remaining in the cell cycle). The number of cells exiting
the cell cycle in the caudal region was about twofold
higher compared to the rostral region in the wild type
cortex (22.0 ± 9.0% versus 10.7 ± 6.3%; n = 6; not
significant) and in EIIa-Cre;Fgfr3+/K644E (18.8 ± 7.5%
versus 8.55 ± 4.9%; n = 6; p = 0.022). However, no
significant difference was observed between wild type
and EIIa-Cre;Fgfr3+/K644E cortices at either the rostral or
caudal level (n = 6).
Prolonged neurogenesis in the caudal Fgfr3 mutant cortex
The vast majority of cortical neurons is generated during
11 cell cycles between E11 and E18 in mice [43, 44]. The
shorter Tc and TG1 described above could result in
completion of progenitor proliferation at an earlier
stage, or might lead to additional cell cycles within the
neurogenic phase during E11-E18. To distinguish
between these possibilities, we analyzed the incorpora-
tion of BrdU in cortical progenitors at the latest stage of
neurogenesis, E18.5, a time point when cortical neuro-
genesis is coming to completion.
Although fewer than at E11-E14 [26], significant
numbers of proliferating progenitor cells were still
evident within the dorsal VZ/SVZ in the wild-type cortex
at E18.5 (Figure 6d). Numbers of BrdU+ proliferating
cells were similar in rostral cortical regions in wild type
and EIIa-Cre;Fgfr3+/K644E. In contrast, in caudal regions,
the number of BrdU+ cells was increased by twofold in
the EIIa-Cre;Fgfr3+/K644E cortex compared to wild type
(n = 6; p = 1.0 × 10-5). This suggests that cortical pro-
genitors in the caudal EIIa-Cre;Fgfr3+/K644E cortex do not
complete proliferative activity prematurely, despite a
shorter Tc and TG1. Rather, progenitors evidently go
through an increased number of cell cycles, indicating an
increased proliferative capacity and prolonged neuro-
genic phase.
Increase of intermediate progenitor cells in the
Fgfr3 mutant cortex
The developing cortical VZ/SVZ contains two distinct
populations of progenitors for glutamatergic projection
neurons, known as radial glia and intermediate progeni-
tor cells (IPCs) [45-47]. We next investigated how the
two progenitor populations are differentially regulated
in rostral and caudal regions of the EIIa-Cre;Fgfr3+/K644E
cortex, using markers specific for each population,
namely Pax6 (radial glia) and Tbr2 (IPCs) [47] (Figure
6 and additional file 1).
Whereas total proliferating cells in the VZ/SVZ were
increased in EIIa-Cre;Fgfr3+/K644E in the caudal region
(Figure 6d), no statistically significant differences were
observed in the total number of proliferating radial glia
(BrdU+Pax6+ double-labeled) in the EIIa-Cre;Fgfr3+/K644E
compared to the wild-type VZ (Figure 6e). In addition,
the total numbers of radial glia (Pax6+) were not
significantly different between wild type and EIIa-Cre;
Fgfr3+/K644E at either the rostral (61.0 ± 16.1 and 46.8 ±
9.8 cells, respectively) or caudal level (48.7 ± 6.6 and
44.2 ± 5.6 cells, respectively; n = 6). In contrast, the total
numbers of IPCs (Tbr2+) showed a twofold increase in
EIIa-Cre;Fgfr3+/K644E compared to wild type in the caudal
cortex (n = 6; p = 9.5 × 10-7), with no significant
difference in rostral regions (Figure 6f). However, the
proportions of proliferating IPCs (BrdU+Tbr2+ double-
labeled) as a fraction of total progenitors (BrdU+) were
increased drastically at both the rostral (2.5-fold; n = 6;
p = 2.6 × 10-4) and caudal (2-fold; n = 6; p = 8.4 × 10-3)
levels in the EIIa-Cre;Fgfr3+/K644E cortex (Figure 6g),
indicating that proliferating IPCs were increased in the
EIIa-Cre;Fgfr3+/K644E cortex compared to wild type at
both rostral and caudal regions. Finally, we examined
the proliferating population of each progenitor type by
quantifying proliferating radial glia and IPCs relative to
the total number of each. Changes in the proportions of
Table 3: Summary of cell cycle parameters
Rostral telencephalon Caudal telencephalon Difference
Cell cycle parameter Wt (h) +/E (h) %Wt Wt (h) +/E (h) %Wt Wt versus +/E
Growth fraction 0.99 0.99 100 0.98 0.96 98
Time to reach max. LI 10.10 9.70 96 10.44 8.77 84 -1 hr 40 min
TC 13.32 13.31 100 13.35 11.74 88 -1 hr 37 min
TS 3.22 3.62 112 2.91 2.97 102 4 min
TG2+M 2.0 2.0 100 4 min
TM 0.80 0.87 109 4 min
TG2 1.2 1.13 94
TG1 8.44 6.77 80 -1 hr 40 min
Cell cycle parameters were determined in the rostral and caudal regions of the EIIa-Cre;Fgfr3+/K644E (+/E) and wild type (Wt) littermate cortical
primordium at E12.5. Four embryos per genotype and two counting boxes per sample were used at each time point. TG1, TG2, and TM were
determined only in the caudal region where a difference in Tc was observed. Three embryos per genotype and one to two counting boxes per sample
were used.
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proliferating radial glia were not statistically significant
when comparing EIIa-Cre;Fgfr3+/K644E and wild type
cortex (Figure 6h), while proliferating IPCs increased
by 2.2-fold (n = 6; p = 1.7 × 10-3) and 2.5-fold (n = 6;
p = 1.7 × 10-3) in the rostral and caudal regions,
respectively (Figure 6i).
In summary, the results show that the total numbers
of both proliferating progenitors and IPCs were
increased in the caudal cortex of EIIa-Cre;Fgfr3+/K644E
mice, and that an increase in the proliferating
Figure 5
Cell cycle exit was unchanged in the EIIa-Cre;Fgfr3+/
K644E cortical primordium at E12.5. (a, b) Double
immunohistochemistry labeled bromodeoxyuridine+ (BrdU+;
green) and Ki67+ (red) cells 24 hours after BrdU injection.
Cells labeled with BrdU can either remain in the cell cycle
(BrdU+Ki67+; yellow, arrowheads) or exit the cell cycle
(BrdU+Ki67-; green, asterisks). Panels (a, b) are
representative images of the dorsal region of the caudal
cortical primordium in wild-type (Wt) and EIIa-Cre;Fgfr3+/
K644E, respectively. (c) Cells that had exited the cell cycle
were counted within a 50 μm channel in the dorsal region
and their percentage was calculated by dividing the number
of BrdU+Ki67- cells by that of BrdU+ cells (n = 6; p = 0.022,
Student's t-test, indicated by *). Three embryos per genotype
and two counting boxes per sample were used (n = 6). Scale
bar: 35 μm.
Figure 6
Regulation of proliferating progenitor cells in the
EIIa-Cre;Fgfr3+/K644E cortex at E18.5. (a-c) Time-mated
females were injected with bromodeoxyuridine (BrdU) for 1
hour prior to termination at E18.5. Immunohistochemistry
for Pax6/BrdU (b) and Tbr2/BrdU (c) were used to identify
proliferating radial glia (arrows in (b)) and intermediate
progenitor cell (IPCs; arrows in (c)) on consecutive sections.
Panels are examples of the staining in wild type at the rostral
region. The white dashed line in (b, c) indicates the apical
surface of the VZ. Cells were counted within a 100 μm
channel that spans the ventricular zone (VZ)/subventricular
zone (SVZ), identified by Nissl (a) and by a region containing
the majority of the Tbr2 immunoreactivity (c) (marked with
the yellow dashed line). Three embryos per genotype and
two counting boxes per samples were used (n = 6). Scale bar:
20 μm. (d) Total numbers of proliferating (BrdU+) cells in
the VZ/SVZ in the dorsal cortical regions. (e) Total numbers
of proliferating radial glia (BrdU+Pax6+) in the VZ. (f) Total
numbers of IPCs (Tbr2+) in the VZ/SVZ. (g) Proportion of
proliferating IPCs (BrdU+Tbr2+) within the proliferating
population (BrdU+). (h) Proportions of proliferating radial
glia (BrdU+Pax6+) within the Pax6+ population. (i)
Proportions of proliferating IPCs (BrdU+ Tbr2+) within the
IPC (Tbr2+) population. Asterisks *, **, and *** indicate p
values < 0.05, < 0.005, and < 0.005 by Student's t-test,
respectively; See Results for details.
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IPC population was observed without a significant
increase in the total progenitors in the rostral cortex of
EIIa-Cre;Fgfr3+/K644E.
Increased thickness in the caudal Fgfr3 mutant
cortex at E18.5
The radial unit hypothesis states that the surface area
of the cortex is determined early in corticogenesis by
the number of radial unit founder cells generated by
symmetric progenitor divisions [1]. In contrast, cortical
thickness is thought to be determined by the neuro-
genic output from each radial unit [1], with inter-
mediate progenitors serving to amplify, and possibly
regulate, neuronal output from radial units (the radial
amplification hypothesis) [48]. Previously, we showed
an enlargement of surface area in the EIIa-Cre;Fgfr3+/
K644E mutant cortical primordium compared to wild
type that was visually apparent at E12.5 [29]. Based on
the above theories and our previous observation, we
predicted that cortical thickness should be increased in
the EIIa-Cre;Fgfr3+/K644E mutants due to greater pro-
duction or proliferation of intermediate progenitor
cells.
We measured cortical thickness at early and late stages of
neurogenesis. At E12.5, the cerebral wall consists mostly
of the VZ with a small area of SVZ starting to appear,
particularly in the lateral region, which is apparent with
Tbr2 immunoreactivity [45, 47]. There were no signifi-
cant differences in cortical thickness between the wild
type and EIIa-Cre;Fgfr3+/K644E mutant at either the rostral
or caudal level (data not shown), which is consistent
with our previous report where thickness was measured
at a medial level [29]. At E14.5, the presence of the SVZ
is more apparent, with a concordant increase in Tbr2+
cells, and the cortical plate starts to emerge [45, 47]. We
have indeed shown previously that at E14.5, the cortical
thickness was increased in the EIIa-Cre;Fgfr3+/K644E
mutant by 38.1% (medial level) [29]. In contrast, at
E18.5, more distinct laminar structures emerge in the
cortical plate, although they are not yet mature. An
increase in cortical thickness in EIIa-Cre;Fgfr3+/K644E
compared to wild type was visually apparent at the
caudal level, particularly that of the intermediate zone
and the cortical plate (Figure 7c, d). Our analysis
shows that the thickness of the caudal cortex was
increased by 74% in the EIIa-Cre;Fgfr3+/K644E mutant
compared to wild type embryos (n = 3; p = 0.042), but
rostral cortex thickness was not significantly changed
(Figure 7e). This regional difference likely reflects the
significant increase of IPC numbers, and prolonged
neurogenesis observed in the EIIa-Cre;Fgfr3+/K644E
caudal cortex (Figure 6).
Discussion
In the present study, we demonstrate that genetic models
with biochemically activating kinase-domain mutations
in Fgfr3 (Nestin-Cre;Fgfr3+/K644E and Foxg1-Cre;Fgfr3+/
K644M) show a massive surface area expansion of the
caudolateral cortex, which is highly correlated with the
gradient of Fgfr3 expression in the VZ at early stages of
neurogenesis (summary in Figure 8a). Is the cortical
phenotype of the current Fgfr3 mutant model caused by a
change in patterning or by size expansion of the caudal
region? Little effect was observed on frontal area size
(Figures 1 and 2, and Tables 1 and 2) or transcription
factor gradients in the mutant cortex (Figure 3), suggest-
ing that cortical patterning was not significantly
Figure 7
Increased cortical thickness in the caudal EIIa-Cre;
Fgfr3+/K644E cortex at E18.5. (a-d) Representative coronal
sections of the wild type (wt) (a, c) and EIIa-Cre;Fgfr3+/K644E
dorsal cortex (b, d) at the rostral (a, b) and caudal regions (c,
d) at E18.5 stained with Nissl. The black line indicates an
example of the measurements taken. (e) Quantification of
cortical thickness, comparing the EIIa-Cre;Fgfr3+/K644E
cortex and wild type (n = 3; p = 0.042, Student's t-test,
indicated by *). Scale bar: 330 μm.
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influenced by increased Fgfr3 activity. In contrast, short-
ening of Tc and TG1 (Figure 4 and Table 3) at E12.5, and
augmentation of BrdU incorporation at E18.5 (Figure 6)
were observed selectively in the caudal region of the Fgfr3
mutant cortex, supporting the idea that the relative
'rostral shift' resulted from size expansion of the caudal
region mostly owing to the cell proliferative effects.
Regulation of patterning by Fgfr3
The expression of the rostral signaling factor Fgf8 and
protomap transcription factors, including Pax6, Emx2,
and Coup-Tf1, showed no obvious changes in mice with
kinase-domain mutations in Fgfr3 (EIIa-Cre;Fgfr3+/K644E)
at E9.5 and E11.5-E13.5, respectively (Figure 3). Inter-
estingly, it was also reported that, despite the loss of the
most anterior structure of the forebrain, the changes in
gradients of Emx2 and Pax6 expression were relatively
subtle in Fgfr1 knockout mice (Foxg1-Cre;Fgfr1flox/flox)
[17]. These observations are in contrast to results of Fgf8
over-expression by in utero electroporation [24, 41] and
in genetic models with reduced Fgf8 [7, 8], where graded
expression of transcription factor genes was visibly
shifted according to the changes in Fgf8 signaling.
Genes that define the protomap have been intensively
screened [4]. It is possible that genes other than Pax6,
Emx2, and Coup-Tf1, are regulated in the current model.
For example, transcription factor Sp8 was recently shown
to play a role in cortical area patterning [49, 50].
Regulation of neurogenesis by Fgfr3
In our previous study, we used 1 hour BrdU incorporation
as a measure of cell proliferation in the cortical VZ/SVZ in
the EIIa-Cre;Fgfr3+/K644E developing cortex at E11.5, E12.5
and E13.5 [26]. Graded BrdU incorporation was observed
with the highest increase in the mutant cortex compared
to wild type in the caudal region at E12.5 and E13.5.
Although overall cell proliferation became less profound
as development progressed [43], the magnitude of the
proliferation increase in the mutant progenitor popula-
tion compared to that of wild type became larger. In the
current study, we addressed how cell cycle parameters,
including cell cycle length and cell cycle exit, are regulated
by Fgfr3 early in neurogenesis. We have shown that Fgfr3
activation in caudal regions of the developing forebrain
reduces cell cycle duration (Figure 4 and Table 3). Based
on the cell cycle length hypothesis, whereby shorter cell
cycle length is associated with proliferative rather than
neurogenic division [51], we expected that the shorter cell
cycle length observed in this study would result in an
overall reduction of cells exiting the cell cycle. However,
cell cycle exit was not affected by activation of Fgfr3. A
shift in the subpopulations of progenitors within the VZ
could also influence the overall measurement of cell cycle
duration. However, at E12.5, when we performed the
analysis, the cortical wall consisted mainly of radial glia,
with only a few IPCs present [45, 47]. Therefore, little
influence from the IPC population is expected. Indeed,
little difference in the balance of these progenitor
populations was observed at E12.5 (data not shown).
In contrast, an increase in the progenitor subpopulation
was observed at E18.5 at the very late stage of
Differential signaling
via Fgfr gradients (e.g. Fgfr3)
Fgf8/15/17         Fgf2.. and other Fgfs
Correct area location and size
Patterning  Cell proliferative properties
Pax6
Emx2
Coup-Tf1
Sp8
M1
S1
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M1
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Differential signaling
via multiple Fgf ligands
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Figure 8
A model for the mechanisms of cortical area
formation regulated by Fgf signaling. (a) Summary of
cortical area positioning upon manipulation of Fgf signaling.
Anterior over-expression of Fgf8 caudally shifts cortical
areas, while sequestration of Fgf8 activity by ectopic
expression of a truncated Fgfr3 protein (sFgfr3) leads to a
rostral shift [6]. In the current study, a genetic model of
biochemically active Fgfr3 kinase domain mutant (Fgfr3*)
showed a 'rostral' shift of cortical areas, likely to have
resulted from a massive surface area expansion selectively
occurring in caudal cortical areas. The area positions of Fgfr3
knockout (ko) mice are currently unknown. Cont, control;
Wt, wild type. (b)We hypothesize that, being expressed in a
unique graded pattern at the outset of neurogenesis, Fgfr3,
together with other Fgf receptor members, may regulate
formation of cortical areas, mediating signals from multiple
Fgf ligands with distinct functions and diverse expression
patterns. This study indicates that various proliferative
parameters, including Tc (namely TG1), proliferative
capacities of the cortical progenitors, and radial glia and
intermediate progenitor cell populations, could be regulated
along the Fgfr3 expression gradient. Therefore, Fgf signaling
regulates cortical area formation by controlling both
patterning and cell proliferative properties.
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neurogenesis (Figure 6). The total number of proliferat-
ing progenitors, and the number of IPCs were increased
in the caudal cortex of EIIa-Cre;Fgfr3+/K644E mice,
indicating the prolongation of neurogenesis upon
activation of Fgfr3. In this study, we focused on the
effect of Fgfr3 activation in neurogenesis. Tbr2+ progeni-
tors are known to be glutamatergic in all systems studied
to date, including the developing cortex [52]. In Tbr2-
Gfp mice, which provide short-term lineage tracing, GFP
has never been detected in glia, but only in neurons (T
Kowalczyk and R Hevner, manuscript submitted). How-
ever, Fgfr3 expression has been reported in glial
populations at postnatal stages [53, 54]. Therefore, it
cannot be excluded that a small proportion of glia
contributed to the increase in BrdU incorporation
observed at E18.5 (Figure 6).
Increases in cortical thickness was observed specifically in
the caudal region in EIIa-Cre;Fgfr3+/K644E embryos (Figure
7). Increases in the thickness of the intermediate zone
likely represent radially migrating late-born neurons
resulting from prolonged neurogenesis (Figure 6). The
timing of cell cycle exit is closely linked to laminar fate,
and growing evidence suggests that the upper-layer
neurons are contributed by the SVZ, or IPC, progenitor
population [55, 56]. Given the increase in Tbr2+
progenitors in our mutant mice observed at E18.5, it
would be interesting to examine whether upper neurons
are preferentially increased in the postnatal cortex in Fgfr3
mutant models. Despite the apparent similarities in Fgfr3
expression levels in radial glia and IPC populations, how
Fgfr3 activation preferentially influences Tbr2+ progenitor
proliferation at E18.5 is also an intriguing question,
which needs to be addressed in the future.
The study indicates that Coup-Tf1 functions to increase
overall neurogenesis by promoting cell cycle exit at early to
mid-stages of neurognesis (E11.5 and E15.5) and that
suppression of MAPK and activation of b-catenin signaling
pathways are responsible for this effect [57]. Interestingly,
the study also shows that Coup-Tf1 promotes Fgfr3
expression, making Fgfr3 an interesting downstream target
and possibly an effecter of cortical patterning, translating the
gradients of transcription factors into progenitor prolifera-
tion. However, at this moment this seems to be unlikely as
we have shown in this and previous studies [29] that
activation of Fgfr3 leads to an increase in cortical progenitor
proliferation, little effect on cell cycle exit, and activation of
the MAPK signaling pathway.
Fgfr3 activation as a cause of human cortical
malformation
The current study implicates the importance of FGFR3 in
the normal and pathological development of the
cerebral cortex in humans. Occipitotemporal surface
expansion and hippocampal dysplasia are two promi-
nent characteristics of the cortical malformation in
human TD, a disease caused by kinase-domain muta-
tions in human FGFR3 corresponding to the models
used in this study [34]. Mice do not normally form
sulcus, which is a known limitation of the animal model.
However, the selective surface area expansion in the
caudal cortical area observed in the mouse model
(Figures 1 and 2) is likely to reflect premature gyrifica-
tion of the occipitotemporal cortex in human TD. And
the study supports the hypothesis that human TD
pathology results from an early regional increase of
surface area [34]. In addition, the reduced expression of a
cortical hem marker, Wnt2b, was observed in the EIIa-
Cre;Fgfr3+/K644E cortical primordium (Figure 3). The
increase in Fgf signaling via activation of Fgfr3 may
suppress growth of the hem and/or its differentiation.
Indeed, our preliminary observations of the current
mouse model revealed hippocampal dysplasia with a
visibly apparent reduction in size of CA3/dentate gyrus
(data not shown). The hippocampus phenotype of Fgfr3
mutant models and its mechanism is to be addressed in
a separate report.
Further clarification of Fgfr3 functions in cerebral cortex
development will depend on detailed analysis of the
Fgfr3 knockout cortex. Results from characterization of
cortical patterning in Fgfr3 knockout mice have not been
conclusively reported so far [28]. In our hands, the Fgfr3
knockout mice [27] rarely survive beyond P1 in the C57/
Bl6 background (data not shown). Further investigation
of the Fgfr3 knockout phenotype, possibly in a more
favorable genetic background, must be undertaken.
Regulation of cortical area location and size by Fgf
signaling
We hypothesize that both patterning and progenitor
proliferation are regulated by signaling from the multi-
ple Fgf ligands, possibly utilizing the graded Fgfr3
activity and that of the other Fgf receptor members
present in the cortex (Figure 8b). Different Fgfs could
define positional information within the cortex by
exerting their effects in combination. The Cooperative
Concentration Model [4] suggests that area identities are
specified by the presence of multiple transcription
factors at different concentrations, rather than by sharply
bordered expression of certain genes. Despite over-
lapping expression patterns of Fgfr1, Fgfr2, and Fgfr3
in the cortical primordium, the effect of the Fgfr3
knockout turned out to be surprisingly localized and
specific. Deletion of Fgfr1 (Foxg1-Cre;Fgfr1flox/flox) did not
result in total loss of rostro-caudal patterning in the
cortex, but resulted in a milder change in patterning of
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gene expression, with a loss of the most anterior
telencephalic structures, including the olfactory bulbs
[17]. Similarly, despite the graded expression pattern of
Fgfr3 across the rostrocaudal axis, a selective expansion
of the caudal cortex was observed upon activation of
Fgfr3 in this study, supporting the Cooperative Concen-
tration Model.
In vitro assays showed that the Fgfr3IIIc isoform, the
main alternative splicing isoform in the developing brain
[58], is able to mediate signals from Fgf2, Fgf8, Fgf15,
Fgf17, and Fgf18 with high affinity [15, 22]; however,
binding of Fgf7 produced very little signal [15]. It is
theoretically possible that Fgfr3 could mediate the effects
of Fgf2/8/15/17/18, depending on the ligand expression
domains and its own expression, exerting its effect either
in patterning and/or in progenitor proliferation. The
results of this study, however, indicate that Fgfr3 is
unlikely to mediate the rostral Fgf signals in patterning,
but rather mediates the effect in progenitor proliferation
in the caudal region. In contrast, the rostral Fgf signals
are likely to be mediated by Fgfr1 and Fgfr2 [17, 19]. The
ligand that utilizes Fgfr3 in the caudal region remains
unknown.
Conclusion
We demonstrate that activation of Fgfr3 selectively
promotes growth of the caudolateral (occipitotemporal)
cortex, similar to the cortical malformation observed in
human TD. We provide evidence that activation of Fgfr3
alters caudal-specific cell proliferative properties, namely
shortening of the cell cycle length and prolongation of
neurogenesis, without altering cell cycle exit. Few
changes were observed in early patterning events. Being
expressed in a unique graded pattern at the outset of
neurogenesis, Fgfr3, together with other Fgf receptor
members, may regulate formation of cortical areas.
Materials and methods
Mice
All procedures were performed in accordance with the
Project Licence under Home Office Animal (Scientific
Procedures) Act 1986. Mice heterozygous with the Fgfr3
mutation and with one copy of the Cre gene, including
EIIa-Cre;Fgfr3+/K644E, Nestin-Cre;Fgfr3+/K644E and Foxg1-
Cre;Fgfr3+/K644M, were produced by crossing either
Fgfr3+/K644Eneo [30] or Fgfr3+/K644Mneo [31] with EIIa-Cre
[30], Nestin-Cre [36], or Foxg1-Cre [37], respectively.
Fgfr3+/K644Eneo, Fgfr3+/K644Mneo, and Nestin-Cre colonies
were maintained in C57BL/6. The backgrounds of EIIa-
Cre and Foxg1-Cre were 129;FBV/N and 129Svj, respec-
tively. Animals were genotyped using the K644 mutation
site [30] and the presence of Cre. In all experiments,
littermates with genotypes of +/+; Fgfr3+/+, +/cre; Fgfr3+/+,
or +/+; Fgfr3+/K644E/Mneo, were used as controls.
Analysis of the cortical area position
Mice were perfused by 4% (w/v) paraformaldehyde in
phosphate-buffered saline (PBS). After cryoprotection,
cortices were flat-frozen using the weight of a micro-
scopic slide. Tangential sections (50 μm) were subjected
to immunohistochemistry with anti-mouse 5-hydroxy-
tryptamine (5-HTT; 1:2000; Calbiochem, Nottingham,
UK) [59] or cytochrome C oxidase histochemistry [38].
Sections were incubated in reaction mix containing 40
mg/ml sucrose, 0.15 mg/ml cytochrome C (C-2506;
Sigma, Dorset, UK), 0.5 mg/ml DAB (D-3001, Sigma) in
0.1 M phosphate buffer, at 37°C for 3 hours to
overnight. The measurement of the barrel location was
performed by Image J (NIH).
Cumulative BrdU labeling
Average length of total cell cycle duration (Tc), length of
the S phase (Ts), and growth fraction (GF) were
determined according to published protocols [43, 60,
61]. Mice were time-mated and the day of the vaginal
plug was counted as E0.5. At E12.5, mice were injected
intraperitoneally with BrdU in PBS at 50 μg/g body
weight. Subsequent injections were performed at a
maximum interval of 3 hours, with a final BrdU injection
0.5 hour prior to termination. Embryos were collected at
8 survival points, 0.5, 2.0, 3.5, 5.0, 6.5, 8.0, 9.5 and 11.0
hours after the initial injection. Morphological land-
marks based on plates 1 and 6 at E12.5 [62] were used to
identify sections at the rostral and caudal levels,
respectively. A 25 μm channel spanning the dorsal VZ
was used for counting BrdU-labeled cells. The LI was
calculated as the proportion of BrdU-labeled cells to
total cells. A least-squares curve fit was generated in the
graphs of LI versus survival time post-BrdU injection
using a Microsoft Excel spreadsheet kindly provided by
Professor Richard Nowakowski [42]. The GF was
calculated as the maximum LI value attained over the
experimental period. Tc and Ts were calculated using the
following equations [61]: y-intercept = GF × Ts/Tc; Time
to reach maximum LI = Tc - Ts.
To determine the combined lengths of G2 and M (TG2+M)
phases, a single-injection BrdU-labeling protocol was
used [61]. TG2+M was calculated as the length taken to
label all cells in the M phase (mitotic cells) with BrdU.
Within each 100 μm channel in the dorsomedial cortex,
the percentage of BrdU+pHH3+ cells was determined. MI
was calculated by dividing the number of mitotic cells by
the total number of cells within a 50 μm channel in the
dorsomedial cortex. The duration of M phase (TM) was
then calculated using the following equations: MI = Total
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number of mitotic cells/Total number of cells; TM = Tc ×
MI. TG2 and TG1 were calculated using the following
equations: TG2 = (G2 + M) - TM; TG1 = Tc - Ts - (TG2+M).
Immunohistochemistry
Coronal sections (10 μm) were deparaffinised and
rehydrated. Antigen retrieval was achieved by boiling in
10 mM citrate buffer (pH 6.4) for 30 minutes.
Endogenous peroxidase activity was quenched by 3%
(v/v) hydrogen peroxide for 10 minutes. Blocking was in
10% normal goat serum in PBS. Incubation with the
anti-BrdU antibody (B-44, 1:75; BD Biosciences, Oxford,
UK) was performed overnight at 4°C. The secondary
antibody was applied for 1 hour (mouse Immpress Kit,
VectorLabs, Peterborough, UK). Immunoreactivity was
detected by 3,3'-diaminobenzidine (DAB) and counter-
stained in haematoxylin Harris (Surgipath, Peterbor-
ough, UK). For mitotic index, pHH3 rabbit polyclonal
antibody (1:200; Upstate, Millipore, Herts, UK) and
rabbit secondary antibody (rabbit Immpress Kit, Vector-
Labs) was used. For double immunohistochemistry,
sections were incubated in 2 mol/dm3 HCl for 1 hour
at 37°C after antigen retrieval. Blocking solution was
10% (v/v) normal goat serum, 2% bovine albumin,
0.1% (v/v) Triton-X100 in PBS. Antibodies used were:
anti-Tbr2 (rabbit polyclonal, 1:2000; Chemicon, Not-
tingham, UK); anti-Pax6 (rabbit polyclonal, 1:500;
Covance, Cambridge BioScience, Cambridge, UK); anti-
Ki67 (rabbit polyclonal, 1:1000; Novocastra, New Castle
upon Tyne, UK); goat anti-mouse AlexaFluor 488, and
goat-anti-rabbit AlexaFluor 594 (1:200; Invitrogen,
Paisley, UK). Sections were mounted in VectaSield
(VectorLabs) containing 4',6-diamidino-2-phenylindole
(DAPI).
In situ hybridization
Riboprobe templates were kindly provided by Drs Gail
Martin (Fgf8), John Rubenstein (Coup-Tf1), David Price
(Pax6), Shinichi Aizawa (Emx2), and Wnt2b (Thomas
Theil). Embryos were fixed in 4% (w/v) paraformalde-
hyde/PBS overnight. Embryos were dehydrated and
stored in methanol at -20°C until genotyped. Embryos
were rehydrated in methanol/PBS with 0.1% (v/v)
Tween-20 (PTW). Treatment with 10 μg/ml Proteinase
K/PTW was performed at room temperature for exactly 5
(E9.5) or 15 minutes (E11.5 and E13.5) and the reaction
was stopped by incubation in 4% (w/v) paraformalde-
hyde, 0.1% glutaraldehyde in PBS. Embryos pre-incu-
bated in hybridization buffer (50% (v/v) deionized
formamide, 5 × SSC, 0.8% (v/v) Tween-20, 50 μg/ml
heparin, 1 mg/ml yeast tRNA, 5 mM EDTA, 0.1% (w/v)
CHAPS, 2% (w/v) Blocking Reagent, Roche, Welwyn,
UK) at 65°C for 1 hour. Riboprobes were diluted 1:300
in the hybridization buffer and denatured at 80°C for 10
minutes. Hybridization was performed at 65°C over-
night. Embryos were washed with post-hybridization
buffer (50% (v/v) formamide, 1 × SSC, 0.1% (v/v)
Tween-20) at 65°C, then with Tris-buffered saline (TBS)
with 0.1% (v/v) Tween-20 (TBST) at room temperature.
Embryos were blocked in 2% (w/v) Blocking Reagent
solution (Roche) with 20% (v/v) Sheep serum (S2263,
Sigma) for 2 hours before incubation with anti-DIG
antibody (1:1500; Roche) at 4°C overnight. After washes
with TBST, color reaction was performed with Nitroblue
tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl
phosphate (BCIP) in NTMT (100 mM Tris, pH 9, 100 mM
NaCl, 50 mM MgCl2, 1% (v/v) Tween-20).
Cortical thickness
Comparable regions of EIIa-Cre;Fgfr3+/K644E and wild
type littermates were selected using morphological
landmarks consistent with plates 4 and 12 at E18.5
[62]. Using Image J, five lines were drawn from the
ventricular to the basal surface and an average was
calculated from the length measured. Three embryos
were used per genotype.
Statistics
Student's t-test was performed to test the significance of
difference in numerical data for two-sample unequal
variance with a two-tailed distribution. A standard
deviation is used for presentation of data.
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Additional material
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Increase of proliferating intermediate progenitor cells in the EIIa-
Cre;Fgfr3+/K644E cortex at E18.5. (a-d) Time-mated females were
injected with bromodeoxyuridine (BrdU) for 1 hour prior to termination
at E18.5. Immunohistochemistry for Tbr2 (red) and BrdU (green) were
used to identify proliferating intermediate progenitor cells (IPCs) in
wild-type (a, c) and EIIa-Cre;Fgfr3+/K644E cortex (b, d) in the rostral (a,
b) and caudal regions (c, d). Scale bar: 32 μm.
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